- Report
- August 2023
- 80 Pages
Asia Pacific
From €4143EUR$4,750USD£3,611GBP
- Report
- August 2023
- 70 Pages
Philippines
From €4143EUR$4,750USD£3,611GBP
- Report
- August 2023
- 100 Pages
Italy
From €4143EUR$4,750USD£3,611GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4143EUR$4,750USD£3,611GBP
- Report
- August 2023
- 70 Pages
Russia
From €4143EUR$4,750USD£3,611GBP
- Report
- August 2023
- 70 Pages
Mexico
From €4143EUR$4,750USD£3,611GBP
- Report
- July 2024
- 150 Pages
Global
From €3271EUR$3,750USD£2,851GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3271EUR$3,750USD£2,851GBP
- Report
- May 2025
- 82 Pages
Sweden, Norway, Iceland, ... Sweden, Norway, Iceland, Finland, Denmark
From €1864EUR$2,138USD£1,625GBP
€2486EUR$2,850USD£2,166GBP
- Report
- April 2025
- 75 Pages
United Kingdom
From €1864EUR$2,138USD£1,625GBP
€2486EUR$2,850USD£2,166GBP
- Report
- February 2025
- 105 Pages
Spain
From €1864EUR$2,138USD£1,625GBP
€2486EUR$2,850USD£2,166GBP
- Report
- December 2024
- 100 Pages
Taiwan
From €1864EUR$2,138USD£1,625GBP
€2486EUR$2,850USD£2,166GBP
- Report
- May 2024
- 145 Pages
Global
From €2584EUR$2,963USD£2,252GBP
€3445EUR$3,950USD£3,003GBP
- Report
- February 2024
- 80 Pages
China
From €1864EUR$2,138USD£1,625GBP
€2486EUR$2,850USD£2,166GBP
- Report
- January 2025
- 172 Pages
Global
From €3925EUR$4,500USD£3,421GBP
- Report
- August 2024
- 200 Pages
Global
From €3375EUR$3,869USD£2,941GBP
- Report
- August 2024
- 200 Pages
Global
From €3375EUR$3,869USD£2,941GBP
- Report
- February 2024
- 160 Pages
Philippines
From €2433EUR$2,789USD£2,120GBP
- Report
- October 2023
- 190 Pages
Global
€4008EUR$4,595USD£3,493GBP
- Report
- March 2024
- 114 Pages
Asia Pacific
From €3009EUR$3,450USD£2,623GBP

The Continuous Glucose Monitoring (CGM) market is a subset of the larger glucose testing market. CGM is a technology that allows for the continuous monitoring of glucose levels in the body. It is typically used by people with diabetes to help them better manage their condition. CGM systems consist of a sensor, transmitter, and receiver. The sensor is inserted under the skin and measures glucose levels in the interstitial fluid. The transmitter sends the data to the receiver, which displays the glucose levels. CGM systems can provide real-time data and alert users when their glucose levels are too high or too low.
Some companies in the CGM market include Dexcom, Abbott, Medtronic, and Senseonics. Show Less Read more